Company Overview

Development Stage

About the Company

西安迪赛生物药业有限责任公司是以生物制剂为主体,以化学制剂和中药制剂为两翼的高新技术企业。公司成立于2000年1月,注册资金6500万元,地址西安市红庙坡69号,占地面积33500平方米,总资产1.8亿多元,有员工482人。现可生产冻干粉针剂、小容量注射剂、片剂、颗粒剂、胶囊剂、混悬剂、原料药等八个类型170多种药品,其中胸腺肽系列产品是我公司与清华大学生命科学学院共同研制开发的免疫制剂,曾经获得陕西省名牌产品。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Recruitment Overview / Current Status (1 open positions)

Manage
Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Note: How fast is hiring at 西安迪赛生物药业有限责任公司 growing? 2026: 12 openings, 2025: 6 openings, 2021: 5 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 西安迪赛生物药业有限责任公司? Based on an analysis of 's job postings over the past year, "计算机/网络/技术类" demand: 88.9%, "医疗卫生/美容保健类": 11.1%. For reference only.

— What Are the Salaries Like? (18 records)

Manage
salary range: 4.5K - 10K, 94.4% of roles pay ¥6-10K
Note: salary statistics are based on 18 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 西安迪赛生物药业有限责任公司?94.4% of positions earn 6-10K, Undergraduate salary: ¥。计算机/网络/技术类 average salary ¥7.8K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Job Category

  • 计算机/网络/技术类
    88.9% of total 88.9%
  • 医疗卫生/美容保健类
    11.1% of total 11.1%
  • 市场/公关/媒介类
    5.6% of total 5.6%
  • 经营管理类
    5.6% of total 5.6%

Education

  • 大专
    94.4% of total 94.4%
  • 本科
    5.6% of total 5.6%

Experience

  • 不限
    88.9% of total 88.9%
  • 1-3年
    5.6% of total 5.6%
  • 5-10年
    5.6% of total 5.6%
View Detailed Analysis

What does 西安迪赛生物药业有限责任公司 require? Who is 西安迪赛生物药业有限责任公司 hiring? recruitment: 计算机/网络/技术类占比最多占88.9%,其次是医疗卫生/美容保健类占11.1%. What education can get in at ? 大专占比最多占94.4%,其次是本科占5.6%. Work experience required at ? 不限占比最多占88.9%,其次是1-3年占5.6%. Where are the job locations at ? 西安占比最多占22.2%,其次是长春占11.1%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 6,500万(元)
Legal Representative: 吴建中
Date Established:
Credit Code: 91610104710178671F
Registered Address: 西安市莲湖区红庙坡69号

Partners & Suppliers

药品采购 Source
合作客户 药品生产供应商
与西安交通大学药学院开展产学研合作,共同进行新药研发及技术攻关。 Source
供应商 高校/科研合作
该公司为西安迪赛生物药业有限责任公司的药品配送商,为其提供药品分销服务。 Source
合作客户 医药商业/配送
该公司为西安迪赛生物药业有限责任公司的药品配送商,负责其产品在陕西省内的分销与配送。 Source
合作客户 医药商业/配送

People who follow this company also follow

Competitors (Similar Companies)

“让每个人享受数字生活”
“综合通信解决方案提供商”
“Providing localized technical services for the global smart terminal i”
制药/药业 生物制药 抗生素 肠外营养
生产 工业 纺丝
“Electronic components and advanced technical ceramics industrial base”
“One of the world's major manufacturers of laser processing equipment”
“Expert in analog-digital mixed-signal IC design”
“一家致力于移动终端测试及自动化的方案服务公司。”
制药/药业 医药 抗生素 生物医药
窄带 卫星通信 应急指挥 研发
“Empowering machines to make human life safer and better”
“A well-known supplier of high-end semiconductor process equipment and ”
轻钢 管桁架 轻钢结构 装配式建筑
“A provider of video-centric intelligent IoT solutions and big data ser”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates